Sun 4 Oct 2026 International edition

Hematology & Blood Research Rethinking Quality of Life: Multi-Stakeholder Consensus Calls for Overhaul of Patient-Reported Outcomes in Advanced Blood Cancer Immunotherapies

Laboratory Medicine Decoding the Titans of the Cosmos: How Ultraheavy Particles are Rewriting Modern Astrophysics

Hematology & Blood Research Executive Overview

Medical Biotechnology Unlocking Nature’s Blueprint: Northwestern Chemists Solve a 30-Year Mystery of Rye Pollen Molecules and Their Promise for Cancer Therapy

Hematology & Blood Research Executive Overview

Medical Biotechnology The Queen’s Burden: New Research Reveals How Honeybee Monarchs Offload Toxins Into Their Eggs

Laboratory Medicine Capturing the Genesis of Extreme States: Researchers Unveil Femtosecond-Scale Plasma Dynamics in Breakthrough Experiment

Clinical Trials & Research Neurocrine begins Phase I trial of NBIP-‘1968 triple agonist for obesity

Microbiology & Infectious Diseases Unlocking Earth’s Earliest Menagerie: Pristine Canadian Fossil Site Rewrites the Timeline of Complex Animal Evolution

Oncology & Cancer Research Hijacking the Body’s Defenses: How Triple-Negative Breast Cancer Co-Opts Immune Cells to Build Nerve Networks and Fuel Tumor Growth

Toxicology & Pharmacology Redefining Heart Failure Care: How a Century-Old, Ten-Cent Medication Could Transform Modern Cardiology

Medical Biotechnology Unlocking Nature’s Remedy: International Research Team Discovers Microbial Pathway to Stabilize Toxic Uranium in Contaminated Waters

Archive

Tag: setback

AstraZeneca’s Phase III NSCLC Trial Setback: Re-Evaluating the PD-1 Bispecific Strategy in Advanced Oncology

Clinical Trials & Research

AstraZeneca’s Phase III NSCLC Trial Setback: Re-Evaluating the PD-1 Bispecific Strategy in Advanced Oncology

Executive Overview The landscape of immuno-oncology has long been defined by the pursuit of combination therapies and multi-targeted biologic agents...

23 Aug 2026